Cloning and expression of the transmembranic glycoprotein from human T cell lymphotropic virus in a prokaryotic system;Clonagem e expressão da glicoproteína transmembrana do vírus linfotrópico de células T humanas em sistema procarioto

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 40, Issue 3, 2007, Pages 277-281

  Russo Carbolante, Elisa Maria De Sousa ^a   Penteado, Flora Cristina Lobo ^a,b   Medeiros, Luciene ^a   Kashima, Simone ^a   Takayanagui, Oswaldo M ^a   Covas, Dimas Tadeu ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

gp21; Heterologous expression; HTLV 1; Recombinant proteins

Indexed keywords

MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN;

ANTIGEN ANTIBODY REACTION; ARTICLE; BIOTECHNOLOGY; DIAGNOSTIC KIT; ESCHERICHIA COLI; HUMAN T CELL LEUKEMIA VIRUS 1; MOLECULAR CLONING; PROKARYOTE; PROTEIN EXPRESSION; VIRUS DIAGNOSIS;

ESCHERICHIA COLI; HUMAN T-LYMPHOTROPIC VIRUS 1; PROKARYOTA;

EID: 34547161328     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822007000300005     Document Type: Article

References (24)

1. Andersson S, Thorstensson R, Ramirez KG, Krook A, von Sydow M, Dias F, Biberfeld G. Comparative evaluation of 14 immunoassays for detection of antibodies to the human T-lymphotropic virus types I and II using panels of sera from Sweden and West Africa. Transfusion 39: 845-851, 1999.
2. Carneiro-Proietti ABF, Ribas JG, Catalan-Soares BC, Martins ML, Brito-Mello GEA, Martins-Filho AO, Pinheiro SR, Araujo AQ, Galvão-Castro B, Oliveira MS, Guedes AC, Proietti FA. Infection and disease caused by the human T cell lymphotropic viruses type I and II in Brazil. Revista da Sociedade Brasileira de Medicina Tropical. 35: 499-508, 2002.
3. Centers for Disease Control and Prevention and the USPHS Working Group. Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II). Annals of Internal Medicine 118:448-454, 1993.
4. Gessain, A. Epidemiology of HTLV-I and associated diseases. In: Hollsberg P, Hafler DA (eds) Human T-cell lymphotropic virus I John Wiley and Sons, New York, NY, p. 34-64, 1996.
5. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, The G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2: 407-410, 1985.
6. Hall WW, Ishak R, Zhu SW, Novoa P, Eiraku N, Takahashi H, Ferreira MC, Azevedo V, Ishak MO, Ferreira OC, Monken C, Kurata T. Human T lymphotropic virus type II (HTLV-II): epidemiology, molecular properties, and clinical features of infection. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 13: S204-214, 1996.
7. Harrington WJ, Sheremata W, Hjelle B, Dube DK, Bradshaw P, Foung SK, Snodgrass S, Toedter G, Cabral L, Poiesz B. Spastic ataxia associated with human T-cell lymphotropic virus type II infection. Annals of Neurology 33: 411-414, 1993.
8. Johnson JM, Harrod R and Franchini G. Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1). International Journal of Experimental Pathology 82: 135-147, 2001.
9. Laemmli, UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
10. Ministério da Saúde. Programa Nacional de Doença Sexualmente Transmissíveis/AIDS. AIDS: Boletim Epidemiológico Ano VIII, no 4, 1995.
11. Monteiro-de-Castro MS, Assunção RM, Proietti FA. Spatial distribution of the Human T-Lymphotropic Virus types I and II (HTLV-I/II) infection among blood donors of Hemominas Foundation, Belo Horizonte, Minas Gerais State, Brazil, 1994-1996.Cadernos de Saúde Pública 17: 1219-1230, 2001.
12. Murphy EL, Glynn SA, Fridey J, Sacher RA, Smith JW, Wright DJ, Newman B, Gibble JW, Ameti DI, Nass CC, Schreiber GB, Nemo GJ. Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group. The Journal of Infectious Diseases 176: 1468-1475, 1997.
13. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet 1: 1031-1032, 1986.
14. Pinheiro SR, Lana MA, Proietti ABFC, Oréfice F, Martins MVCL, Proietti FA. HTLV-IHTLV-I associated uveitis, myelopathy, rheumatoid arthritis and Sjogren's syndrome. Arquivos de Neuropsiquiatria 53: 777-781, 1995.
15. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America 77: 7415-7419, 1980.
16. Rodgers-Johnson P, Gajdusek DC, Morgan OS, Zaninovic V, Sarin PS, Graham DS. HTLV-I and HTLV-III antibodies and tropical spastic paraparesis. Lancet 2: 1249, 1985.
17. Saiki RK, Gelfand DH, Stoffel S, Schard SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-91, 1988.
18. Sheremata WA, Harrington Jr WJ, Bradshaw PA, Foung SK, Raffanti SP, Berger JR, Snodgrass S, Resnick L, Poiesz BJ. Association of (tropical) ataxic neuropathy' with HTLV-II. Virus Research 29: 71-77, 1993.
19. Silva EA, Otsuki K, Leite AC, Alamy AH, Sá-Carvalho D, Vicente AC. HTLV-II infection associated with a chronic neurodegenerative disease: clinical and molecular analysis. Journal of Medical Virology 66: 253-257, 2002.
20. Takatsuki K, Yamaguchi K, Kawano F, Hattori T, Nishimura H, Tsuda H, Sanada I, Nakada K, Itai Y. Clinical diversity in adult T-cell leukemia-lymphoma. Cancer Research 45: 4644-4645s, 1985.
21. Thorstensson R, Albert J, Andersson S. Strategies for diagnosis of HTLV-I and -II. Transfusions Complications 42: 780-791, 2002.
22. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proceedings of the National Academy of Science 79: 2031-2035, 1982.
23. Zaninovic' V. HTLV-I associated diseases. In: Zaninovic V (ed) HTLV. Truths and Questions. Fundación MAR-Colciencias, Cali, p.301-313, 1996.
24. Zehender G, De Maddalena C, Osio M, Cavalli B, Parravicini C, Moroni M, Galli M. High prevalence of human T cell lymphotropic virus type II infection in patients affected by human immunodeficiency virus type 1 - associated predominantly sensory polyneuropathy. Journal of Infectious Disease 172: 1595-1598, 1995.